259 related articles for article (PubMed ID: 9218518)
1. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
3. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
[TBL] [Abstract][Full Text] [Related]
4. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
[TBL] [Abstract][Full Text] [Related]
5. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q.
Moore PS; Zamboni G; Brighenti A; Lissandrini D; Antonello D; Capelli P; Rigaud G; Falconi M; Scarpa A
Am J Pathol; 2001 Jan; 158(1):317-21. PubMed ID: 11141506
[TBL] [Abstract][Full Text] [Related]
7. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.
Waber PG; Lee NK; Nisen PD
Oncogene; 1996 Jan; 12(2):365-9. PubMed ID: 8570213
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors.
Kanno H; Shuin T; Kondo K; Yamamoto I; Ito S; Shinonaga M; Yoshida M; Yao M
Cancer Res; 1997 Mar; 57(6):1035-8. PubMed ID: 9067265
[TBL] [Abstract][Full Text] [Related]
9. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
[TBL] [Abstract][Full Text] [Related]
10. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
[TBL] [Abstract][Full Text] [Related]
11. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
[TBL] [Abstract][Full Text] [Related]
12. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis.
Decker HJ; Weidt EJ; Brieger J
Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583
[TBL] [Abstract][Full Text] [Related]
13. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
[TBL] [Abstract][Full Text] [Related]
14. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
[TBL] [Abstract][Full Text] [Related]
15. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
16. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
[TBL] [Abstract][Full Text] [Related]
17. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
[TBL] [Abstract][Full Text] [Related]
18. Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL.
Moore PS; Missiaglia E; Antonello D; Zamò A; Zamboni G; Corleto V; Falconi M; Scarpa A
Genes Chromosomes Cancer; 2001 Oct; 32(2):177-81. PubMed ID: 11550286
[TBL] [Abstract][Full Text] [Related]
19. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
20. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
